Immuno Oncology Assays Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1065722
  • May 2021
  • Biotechnology
  • 137 Pages
The global Immuno Oncology Assays market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Immuno Oncology Assays market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Immuno Oncology Assays market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Immuno Oncology Assays market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, HTG Molecular Diagnostics, Inc., Illumina, Inc., Merck KGaA, PerkinElmer Inc., Thermo Fisher Scientific Inc., Qiagen, Sartorius AG, NanoString Technologies, Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Immuno Oncology Assays market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Immuno Oncology Assays market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Immuno Oncology Assays market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Immuno Oncology Assays market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Immuno Oncology Assays Market:
The Immuno Oncology Assays market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, HTG Molecular Diagnostics, Inc., Illumina, Inc., Merck KGaA, PerkinElmer Inc., Thermo Fisher Scientific Inc., Qiagen, Sartorius AG, NanoString Technologies, Inc.

Immuno Oncology Assays Market Segment Analysis:
By Technology
Immunoassays
PCR
NGS
Flow Cytometry
Others
Indication
Colorectal Cancer
Lung Cancer
Melanoma
Bladder Cancer
Others
Application
Clinical Diagnostics
Research


Geographic Coverage for Immuno Oncology Assays Market:
The market research report on global Immuno Oncology Assays market offers complete analysis across various regions across the world. The Immuno Oncology Assays market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Immuno Oncology Assays market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Immuno Oncology Assays Market Value and Forecast
  • US
  • Canada
Europe Immuno Oncology Assays Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Immuno Oncology Assays Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Immuno Oncology Assays Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Immuno Oncology Assays Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Immuno Oncology Assays market report:
  • The report provides key trends of the global Immuno Oncology Assays market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Immuno Oncology Assays industry
  • The report covers all the recent developments of the Immuno Oncology Assays market and helps to provide current industry updates
  • The report covers a detailed look over the global Immuno Oncology Assays Industry and provides with significant actionable insights
  • The Immuno Oncology Assays market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Immuno Oncology Assays market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Immuno Oncology Assays market
  • Comprehensive analysis of the Immuno Oncology Assays market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Immuno Oncology Assays market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Immuno Oncology Assays market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Immuno Oncology Assays market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Immuno Oncology Assays market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Immuno Oncology Assays market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd
  • HTG Molecular Diagnostics, Inc.
  • Illumina, Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Qiagen
  • Sartorius AG
  • NanoString Technologies, Inc.
  • Immunoassays
  • PCR
  • NGS
  • Flow Cytometry
  • Others
  • Clinical Diagnostics
  • Research

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Immuno Oncology Assays Market Snapshot
          2.1.1. Global Immuno Oncology Assays Market By Technology,2019
               2.1.1.1.Immunoassays
               2.1.1.2.PCR
               2.1.1.3.NGS
               2.1.1.4.Flow Cytometry
               2.1.1.5.Others
          2.1.2. Global Immuno Oncology Assays Market By Application,2019
               2.1.2.1.Clinical Diagnostics
               2.1.2.2.Research
          2.1.3. Global Immuno Oncology Assays Market By End-use,2019
          2.1.4. Global Immuno Oncology Assays Market By Geography,2019

3. Global Immuno Oncology Assays Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Immuno Oncology Assays Market Size (US$), By Technology, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Technology, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Technology, 2020
     4.2. Global Immuno Oncology Assays Market Size (US$), By Technology, 2018 – 2028

5. Global Immuno Oncology Assays Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Immuno Oncology Assays Market Size (US$), By Application, 2018 – 2028

6. Global Immuno Oncology Assays Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Immuno Oncology Assays Market Size (US$), By End-use, 2018 – 2028

7. Global Immuno Oncology Assays Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Immuno Oncology Assays Market Analysis, 2018 – 2028 
          7.2.1. North America Immuno Oncology Assays Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Immuno Oncology Assays Market Size (US$), By Technology, 2018 – 2028
          7.2.3. North America Immuno Oncology Assays Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Immuno Oncology Assays Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Immuno Oncology Assays Market Analysis, 2018 – 2028 
          7.3.1.  Europe Immuno Oncology Assays Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Immuno Oncology Assays Market Size (US$), By Technology, 2018 – 2028
          7.3.3. Europe Immuno Oncology Assays Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Immuno Oncology Assays Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Immuno Oncology Assays Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Immuno Oncology Assays Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Immuno Oncology Assays Market Size (US$), By Technology, 2018 – 2028
          7.4.3. Asia Pacific Immuno Oncology Assays Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Immuno Oncology Assays Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Immuno Oncology Assays Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Immuno Oncology Assays Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Immuno Oncology Assays Market Size (US$), By Technology, 2018 – 2028
          7.5.3. Latin America Immuno Oncology Assays Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Immuno Oncology Assays Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Immuno Oncology Assays Market Analysis, 2018 – 2028 
          7.6.1.  MEA Immuno Oncology Assays Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Immuno Oncology Assays Market Size (US$), By Technology, 2018 – 2028
          7.6.3. MEA Immuno Oncology Assays Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Immuno Oncology Assays Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Immuno Oncology Assays Providers
        8.4.1 Agilent Technologies, Inc.
                8.4.1.1 Business Description
                8.4.1.2 Agilent Technologies, Inc. Geographic Operations
                8.4.1.3 Agilent Technologies, Inc. Financial Information
                8.4.1.4 Agilent Technologies, Inc. Product Positions/Portfolio
                8.4.1.5 Agilent Technologies, Inc. Key Developments
        8.4.2 F. Hoffmann-La Roche Ltd
                8.4.2.1 Business Description
                8.4.2.2 F. Hoffmann-La Roche Ltd Geographic Operations
                8.4.2.3 F. Hoffmann-La Roche Ltd Financial Information
                8.4.2.4 F. Hoffmann-La Roche Ltd Product Positions/Portfolio
                8.4.2.5 F. Hoffmann-La Roche Ltd Key Developments
        8.4.3 HTG Molecular Diagnostics, Inc.
                8.4.3.1 Business Description
                8.4.3.2 HTG Molecular Diagnostics, Inc. Geographic Operations
                8.4.3.3 HTG Molecular Diagnostics, Inc. Financial Information
                8.4.3.4 HTG Molecular Diagnostics, Inc. Product Positions/Portfolio
                8.4.3.5 HTG Molecular Diagnostics, Inc. Key Developments
        8.4.4 Illumina, Inc.
                8.4.4.1 Business Description
                8.4.4.2 Illumina, Inc. Geographic Operations
                8.4.4.3 Illumina, Inc. Financial Information
                8.4.4.4 Illumina, Inc. Product Positions/Portfolio
                8.4.4.5 Illumina, Inc. Key Developments
        8.4.5 Merck KGaA
                8.4.5.1 Business Description
                8.4.5.2 Merck KGaA Geographic Operations
                8.4.5.3 Merck KGaA Financial Information
                8.4.5.4 Merck KGaA Product Positions/Portfolio
                8.4.5.5 Merck KGaA Key Developments
        8.4.6 PerkinElmer Inc.
                8.4.6.1 Business Description
                8.4.6.2 PerkinElmer Inc. Geographic Operations
                8.4.6.3 PerkinElmer Inc. Financial Information
                8.4.6.4 PerkinElmer Inc. Product Positions/Portfolio
                8.4.6.5 PerkinElmer Inc. Key Developments
        8.4.7 Thermo Fisher Scientific Inc.
                8.4.7.1 Business Description
                8.4.7.2 Thermo Fisher Scientific Inc. Geographic Operations
                8.4.7.3 Thermo Fisher Scientific Inc. Financial Information
                8.4.7.4 Thermo Fisher Scientific Inc. Product Positions/Portfolio
                8.4.7.5 Thermo Fisher Scientific Inc. Key Developments
        8.4.8 Qiagen
                8.4.8.1 Business Description
                8.4.8.2 Qiagen Geographic Operations
                8.4.8.3 Qiagen Financial Information
                8.4.8.4 Qiagen Product Positions/Portfolio
                8.4.8.5 Qiagen Key Developments
        8.4.9 Sartorius AG
                8.4.9.1 Business Description
                8.4.9.2 Sartorius AG Geographic Operations
                8.4.9.3 Sartorius AG Financial Information
                8.4.9.4 Sartorius AG Product Positions/Portfolio
                8.4.9.5 Sartorius AG Key Developments
        8.4.10 NanoString Technologies, Inc.
                8.4.10.1 Business Description
                8.4.10.2 NanoString Technologies, Inc. Geographic Operations
                8.4.10.3 NanoString Technologies, Inc. Financial Information
                8.4.10.4 NanoString Technologies, Inc. Product Positions/Portfolio
                8.4.10.5 NanoString Technologies, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Immuno Oncology Assays Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Immuno Oncology Assays Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Immuno Oncology Assays Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Immuno Oncology Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Immuno Oncology Assays Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Immuno Oncology Assays Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Immuno Oncology Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Immuno Oncology Assays Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Immuno Oncology Assays Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Immuno Oncology Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Immuno Oncology Assays Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Immuno Oncology Assays Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Immuno Oncology Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Immuno Oncology Assays Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Immuno Oncology Assays Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Immuno Oncology Assays Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Immuno Oncology Assays: Market Segmentation 
FIG. 2 Global Immuno Oncology Assays Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Immuno Oncology Assays Market, By Technology, 2019 (US$ Mn) 
FIG. 5 Global Immuno Oncology Assays Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Immuno Oncology Assays Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Immuno Oncology Assays Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Immuno Oncology Assays Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Immuno Oncology Assays Providers, 2019
FIG. 11 Global Immuno Oncology Assays Market Revenue Contribution, By Technology, 2019 & 2028 (Value %) 
FIG. 12 Global Immuno Oncology Assays Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Immuno Oncology Assays Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Immuno Oncology Assays Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Immuno Oncology Assays Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Immuno Oncology Assays Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Immuno Oncology Assays Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Immuno Oncology Assays Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Immuno Oncology Assays market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Immuno Oncology Assays Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Immuno Oncology Assays Market Value, By Segment1, 2018 – 2028
TABLE  North America Immuno Oncology Assays Market Value, By Segment2, 2018 – 2028
TABLE  North America Immuno Oncology Assays Market Value, By Country, 2018 – 2028
TABLE  Europe Immuno Oncology Assays Market Value, By Segment1, 2018 – 2028
TABLE  Europe Immuno Oncology Assays Market Value, By Segment2, 2018 – 2028
TABLE  Europe Immuno Oncology Assays Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Immuno Oncology Assays Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Immuno Oncology Assays Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Immuno Oncology Assays Market Value, By Country, 2018 – 2028
TABLE  Latin America Immuno Oncology Assays Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Immuno Oncology Assays Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Immuno Oncology Assays Market Value, By Country, 2018 – 2028
TABLE  MEA Immuno Oncology Assays Market Value, By Segment1, 2018 – 2028
TABLE  MEA Immuno Oncology Assays Market Value, By Segment2, 2018 – 2028
TABLE  MEA Immuno Oncology Assays Market Value, By Country, 2018 – 2028
TABLE  Agilent Technologies, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  HTG Molecular Diagnostics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Illumina, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck KGaA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  PerkinElmer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Qiagen: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sartorius AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  NanoString Technologies, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Immuno Oncology Assays Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Immuno Oncology Assays Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Immuno Oncology Assays Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Immuno Oncology Assays Market, By Geography, 2019 (US$ Mn)
FIG.  Global Immuno Oncology Assays Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Immuno Oncology Assays Providers, 2016
FIG.  Global Immuno Oncology Assays Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global PCR Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global NGS Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Flow Cytometry Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Immuno Oncology Assays Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Research Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Immuno Oncology Assays Market Value, 2018 – 2028, (US$ Mn)